National Institutes of Health (NIH) β 2018 Investments
254 investments dated 2018 Β· page 2 of 2 Β· listed companies and verified rows first Β· show all
Sound Pharmaceuticals (SPI) is a Seattle-based biotech developing drug therapeutics, including its lead candidate SPI-1005, to prevent and treat sensorineural hearing loss, tinnitus, and Meniere's disease.
BiotechHealthtechSeattle, US
Glenn Kawasaki(Director)James Paul Rickey(Executive Officer)Jonathan Kil(Executive Officer, Director)Eric Lynch(Executive Officer, Director)Joseph Ashley(Director)
Spinogenix develops first-in-class small-molecule investigational therapeutics designed to restore brain synapses in neurodegenerative, neuropsychiatric, and neurodevelopmental conditions such as ALS, Alzheimer's disease, schizophrenia, and Fragile X Syndrome.
BiotechDeep TechHealthtechLos Angeles, US
Stella Sarraf, Ph.D.(Executive Officer, Director)Stella Sarraf(Founder & CEO)Franz Hefti(Director)Josh Swartz(Director)
BoardSteve Young(Director)Jerre L. Stead(Director)
StemBioSys develops cell culture technology, including the patented CELLvo Matrix that replicates the body's physiological microenvironment to expand mesenchymal stem cells and specialty cells while preserving their stem-like properties.
BiotechHealthtechLongevityMedical DevicesSan Antonio, US
Jean Cheever(Director)Chen Xiao-Dong(Director)Mark D Horsey(Executive Officer)Robert Hutchens(Director)John W Feik(Director)Steven Davis(Co-founder)
BiotechHouston, US
George Davitt(Director)Bruce Given(Director)Christopher Jorgensen(Director)Marc Loev(Director)Motter Clarice(Executive Officer)
BiotechPortland, US
F Andrew Ray(Director)Mark F Holifer(Executive Officer, Director, Promoter)Emmanuel Akporiaye(Executive Officer, Director, Promoter)Rebecca Akporiaye(Executive Officer, Director)Andrew D Thaler(Executive Officer)Denis R Burger(Director)
Mattek develops in vitro life science technologies, including lab-grown 3D human epithelial tissue models, banks of primary human cells, and cell culture dishes and plates ("Cultureware") designed for cell growth and imaging.
BiotechHealthtechNew Materials
Michael Johnson(Cofounder)
BetteRx is a pharmacy technology company that provides automated compounding systems and software to enable pharmacists to safely and efficiently prepare personalized, customized medications at scale while maintaining FDA compliance.
HardwareHealthtechMedical Devices
Anthony Marsella(Founder & CEO)Daniel DeCiccio(Co-Founder & CTO)
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.